KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Divestments (2019 - 2022)

Boston Scientific (BSX) has disclosed Divestments for 9 consecutive years, with $5.0 million as the latest value for Q1 2022.

  • Quarterly Divestments fell 99.38% to $5.0 million in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2022, down 99.39% year-over-year, with the annual reading at $5.0 million for FY2022, 99.39% down from the prior year.
  • Divestments hit $5.0 million in Q1 2022 for Boston Scientific, down from $25.0 million in the prior quarter.
  • In the past five years, Divestments ranged from a high of $801.0 million in Q1 2021 to a low of $5.0 million in Q1 2022.
  • Historically, Divestments has averaged $187.2 million across 4 years, with a median of $25.0 million in 2021.
  • Biggest YoY gain for Divestments was 99.38% in 2022; the steepest drop was 99.38% in 2022.
  • Year by year, Divestments stood at $90.0 million in 2019, then tumbled by 83.33% to $15.0 million in 2020, then soared by 66.67% to $25.0 million in 2021, then plummeted by 80.0% to $5.0 million in 2022.
  • Business Quant data shows Divestments for BSX at $5.0 million in Q1 2022, $25.0 million in Q4 2021, and $801.0 million in Q1 2021.